Estradiol Completed Phase 4 Trials for Polycystic Ovaries Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00640224Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study